NO ASSOCIATION OF APOLIPOPROTEIN A-IV CODON-347 AND CODON-360 VARIATION WITH ATHEROSCLEROSIS AND LIPID TRANSPORT IN A SAMPLE OF MIXED HYPERLIPIDEMICS

被引:12
作者
CARREJO, MH
SHARRETT, AR
PATSCH, W
BOERWINKLE, E
机构
[1] UNIV TEXAS, HLTH SCI CTR, CTR HUMAN GENET, HOUSTON, TX 77225 USA
[2] BAYLOR COLL MED, DEPT INTERNAL MED, HOUSTON, TX 77030 USA
[3] NHLBI, BETHESDA, MD 20892 USA
关键词
APOLIPOPROTEIN A-IV; COMBINED HYPERLIPIDEMIA; HYPERTRIGLYCERIDEMIA;
D O I
10.1002/gepi.1370120405
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
Genetic variation at the apolipoprotein (ape) A-I/C-III/A-IV gene cluster on chromosome 11 has been associated with differences in occurrence of atherosclerosis and with variability in lipid levels among hypercholesterolemic-hypertriglyceridemic individuals. The functional cause of the association is not known, but polymorphisms of the apo A-IV gene are of interest because apo A-IV is involved in both triglyceride and cholesterol metabolism. Two mutations in the apo A-IV gene, 347T-->S and 360Q-->H, are known to cause amino acid substitutions in the mature protein. These polymorphisms were typed in a sample of 119 subjects with high cholesterol and high triglycerides in whom carotid artery wall thickness was previously shown to be strongly associated with silent polymorphic variation in the A-I/C-III/A-IV gene cluster. The relative allele frequencies were 0.83 and 0.17 for codon 347T-->S, and 0.95 and 0.05 for codon 360Q-->H. These polymorphisms did not show a statistically significant relationship with prevalent hypertension, diabetes, or cardiovascular disease or with plasma lipid levels. Most importantly, these amino acid substitutions in apo A-IV were not associated with carotid artery wall thickness. Therefore, the genetic cause of disease variability in a sample of mixed hyperlipidemics is not amino acid substitutions in codons 347 or 360 of the apolipoprotein A-IV gene. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:371 / 380
页数:10
相关论文
共 32 条
[1]  
[Anonymous], 1991, J Neuroimaging, V1, P68
[2]   PLASMA TRIGLYCERIDE AND CORONARY HEART-DISEASE [J].
AUSTIN, MA .
ARTERIOSCLEROSIS AND THROMBOSIS, 1991, 11 (01) :2-14
[3]  
BOERWINKLE E, 1988, AM J HUM GENET, V42, P104
[4]   2 POLYMORPHISMS FOR AMINO-ACID SUBSTITUTIONS IN THE APOA4 GENE [J].
BOERWINKLE, E ;
VISVIKIS, S ;
CHAN, L .
NUCLEIC ACIDS RESEARCH, 1990, 18 (16) :4966-4966
[5]  
BOERWINKLE E, 1990, CURR OPIN LIPIDOL, V1, P151
[6]  
BROWN SA, 1988, CLIN CHEM, V34, P920
[7]  
BROWN SA, 1990, CLIN CHEM, V36, P1662
[8]  
Conover W.J., 1999, PRACTICAL NONPARAMET, P428, DOI DOI 10.1002/BIMJ.19730150311
[9]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[10]  
Gaubatz J W, 1986, Methods Enzymol, V129, P167